RxSight RXST Cash Flow Statement (2020-2026)

NASDAQ RXST
$6.33 -0.12 (-1.86%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

RxSight Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

RxSight reported cash from operations of -$9.54M and free cash flow of -$11.49M for the quarter ended Jun 2026, down 118.0% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.67M-15.75M-17.60M-16.73M-16.82M-1.59M-13.21M-13.80M-12.41M1.04M-9.10M-6.08M-6.34M-0.13M-8.19M-11.79M-9.82M-0.92M-15.88M-12.10M
Share-based CompensationStock Comp.
5.45M2.92M6.15M8.00M6.90M2.96M7.35M10.90M9.60M4.42M6.56M15.30M6.02M7.28M7.14M24.20M21.00M7.82M21.40M29.40M
Gains from Investment SecuritiesGains Investment
-1.50M5.43M
Asset Writedowns and ImpairmentWritedown
0.61M0.01M0.07M0.05M0.33M0.30M0.01M0.00M-0.00M0.15M0.11M0.06M0.17M0.07M0.03M1.22M0.07M0.62M0.06M1.12M
Cash from OperationsCash from Ops.
-13.76M-8.72M-14.98M-14.82M-15.19M-13.85M-17.76M-7.55M-7.98M-8.30M-9.31M-4.03M0.65M-4.26M-8.83M-4.38M-1.19M-1.12M-10.89M-9.54M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00M0.01M0.05M0.18M0.39M0.78M1.26M1.70M1.59M1.58M1.50M2.07M2.77M2.63M2.41M2.13M2.14M1.83M1.85M1.75M
Amortization of Deferred ChargesAmort. Deferred Charges
0.13M0.13M0.13M0.14M0.14M0.14M0.14M0.14M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
1.01M1.02M1.02M1.01M0.94M0.92M0.95M0.99M1.08M1.05M1.11M0.81M1.13M0.52M0.78M0.79M0.85M0.85M0.83M1.00M
Change in Working Capital
Change in ReceivablesChange Receivables
0.42M0.50M0.76M1.26M2.14M1.94M1.71M0.63M1.95M5.04M1.27M4.17M-0.32M4.68M0.93M-2.89M-3.91M-0.79M-0.94M-3.73M
Change in InventoryChange Inventory
1.51M-1.40M0.53M3.18M4.05M-0.20M3.24M-0.12M0.98M-1.35M1.39M0.80M2.40M0.41M1.60M2.71M3.96M3.23M3.37M3.36M
Change in Account PayablesChange Payables
-0.74M0.10M0.70M0.65M0.98M-1.70M1.16M0.16M0.08M-0.16M1.18M-0.39M0.04M0.12M2.23M-3.72M-0.09M2.20M1.58M-0.63M
Change in Accured ExpensesChange Accured Exp.
1.24M1.60M-1.45M1.47M2.37M2.43M-3.49M1.48M2.13M2.19M-3.74M2.40M3.72M3.48M-6.16M1.03M1.56M1.70M-1.25M-0.26M
Investing Activities
Capital ExpendituresCapex
0.25M0.36M0.37M1.08M0.58M0.36M0.75M1.82M0.65M1.59M1.97M1.52M1.10M0.85M0.57M1.54M0.58M1.14M0.76M1.96M
Change in Acquisitions & DivestmentsChange Acquisitions
15.00M25.00M90.00M45.00M75.00M45.00M60.00M55.00M90.00M50.00M74.00M45.00M69.00M55.00M60.00M50.00M60.00M90.00M110.00M100.00M
Cash from Investing ActivitiesCash from Investing
-80.24M-35.35M-14.86M43.84M0.56M10.40M-48.37M4.39M17.27M4.57M24.27M-115.64M-9.26M1.32M20.86M14.65M-9.00M-9.61M8.85M4.65M
Financing Activities
Other financing activitiesOther financing
118.25M-118.03M0.31M-0.31M54.05M108.10M0.70M-0.70M0.10M0.10M
Cash from Financing ActivitiesCash from Financing
120.55M0.40M-0.10M0.58M-0.46M6.31M65.31M0.89M-8.23M3.56M7.99M111.47M0.88M2.98M-0.73M2.06M-0.53M1.06M-0.34M0.66M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.06M0.53M1.15M1.27M1.47M0.79M1.20M1.23M1.51M1.64M
Net Equity Issued and RepurchasedNet Equity Issued
0.14M0.59M0.76M3.13M11.70M3.58M10.15M3.84M3.83M2.99M0.70M2.07M0.13M1.06M0.14M0.67M
Additional items
Exchange Rate EffectFX Effect
-0.00M-0.00M-0.01M-0.01M-0.01M0.01M0.00M0.00M-0.01M0.01M-0.00M-0.00M0.01M-0.01M0.01M0.01M-0.00M-0.01M0.00M0.00M
Change in Cash
26.55M-43.67M-0.23M-0.13M-15.09M2.87M-0.82M-2.26M1.05M-0.17M22.95M-8.20M-7.72M0.02M11.29M12.36M-10.72M-9.68M-2.38M-4.22M
Free Cash FlowFCF
-14.01M-9.09M-15.36M-15.90M-15.77M-14.22M-18.51M-9.37M-8.63M-9.89M-11.28M-5.55M-0.45M-5.11M-9.41M-5.91M-1.77M-2.25M-11.65M-11.49M
Net Cash FlowNCF
26.55M-43.66M-29.94M29.60M-15.08M2.86M-0.82M-2.26M1.06M-0.17M22.96M-8.20M-7.73M0.04M11.29M12.34M-10.72M-9.67M-2.38M-4.22M